XML 49 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheet Components
9 Months Ended
Oct. 26, 2014
Notes to financial statements [Abstract]  
Balance Sheet Components
Balance Sheet Components
 
Certain balance sheet components are as follows:
 
October 26,
 
January 26,
 
2014
 
2014
Inventories:
(In thousands)
Raw materials
$
128,588

 
$
126,896

Work in-process
78,849

 
94,844

Finished goods
200,644

 
166,025

Total inventories
$
408,081

 
$
387,765



At October 26, 2014, we had outstanding inventory purchase obligations totaling $512.2 million.

 
October 26,
 
January 26,
 
2014
 
2014
Accrued Liabilities and Other Current Liabilities:
(In thousands)
Deferred revenue, short-term
$
240,829

 
$
265,616

Accrued customer programs (1)
154,185

 
157,840

Accrued payroll and related expenses
98,870

 
109,721

Accrued legal settlement (2)
30,600

 
30,600

Customer advances
17,806

 
9,297

Professional service fees
12,368

 
13,572

Warranty accrual (3)
7,222

 
7,571

Coupon interest on Notes
6,292

 
2,500

Taxes payable, short-term
5,512

 
2,378

Facilities related liabilities
15,781

 
5,216

Other
16,345

 
16,794

Total accrued liabilities and other current liabilities
$
605,810

 
$
621,105

      
(1) Please refer to Note 1 of the Notes to the Consolidated Financial Statements in our Annual Report on Form 10-K for the fiscal year ended January 26, 2014, for discussion regarding the nature of accrued customer programs and their accounting treatment related to our revenue recognition policies and estimates. 
(2)  Please refer to Note 12 of these Notes to Condensed Consolidated Financial Statements for discussion regarding the 3dfx litigation. 
(3)  Please refer to Note 10 of these Notes to Condensed Consolidated Financial Statements for discussion regarding the warranty accrual.
 
October 26,
 
January 26,
 
2014
 
2014
Other Long-Term Liabilities:
(In thousands)
Deferred income tax liability
$
210,388

 
$
157,953

Income taxes payable, long-term
122,854

 
119,977

Deferred revenue, long-term (1)

 
172,199

Asset retirement obligation
7,406

 
11,056

Other
14,485

 
13,940

Total other long-term liabilities
$
355,133

 
$
475,125



(1) Consists primarily of annual consideration received in advance of our performance obligation under our patent cross licensing agreement with Intel Corporation entered into in January 2011. The decrease in deferred revenue, long-term, is a result of revenue recognized during the nine months ended October 26, 2014.